Basal Cell Carcinoma
Basal cell carcinoma is the most common skin cancer and cancer worldwide. Due to a variety of factors, its incidence continues to rise over recent decades.
Both genetic predisposition and environmental factors such as sun exposure are involved in basal cell carcinoma development. People with fairer skin types are usually more at risk for developing this skin cancer. However, people of all skin types are able to develop basal cell carcinomas.
Although basal cell carcinomas are associated with a lower spread (metastatic) rate to other parts of the body compared to squamous cell carcinomas and melanomas, basal cell carcinomas can grow quite large and cause extensive local structural damage and disfigurement. This is particularly important for areas of the body such as the face and ears. It is very important to diagnose and treat basal cell carcinomas at an early stage.
There are many treatments options for basal cell carcinomas including Mohs micrographic surgery and standard surgical excisions. The exact choice of treatment will depend on a multitude of factors including but not limited to the basal cell carcinoma type, location, size, and the patients’ overall medical condition. Once a person is diagnosed with basal cell carcinoma, regular skin checks are important to prevent recurrence and new growths of this skin cancer.
Call Wall Street Dermatology today to schedule your appointment for a skin cancer consultation. Dr. Julia Tzu, one of very few dermatologists in the United States who is double fellowship trained in Mohs surgery (skin cancer surgery) and dermatopathology (interpretation of skin tissue specimens), will guide you towards the best treatment option for your particular skin cancer.